Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4576519
Max Phase: Preclinical
Molecular Formula: C35H41ClN6O3
Molecular Weight: 629.21
Molecule Type: Unknown
Associated Items:
ID: ALA4576519
Max Phase: Preclinical
Molecular Formula: C35H41ClN6O3
Molecular Weight: 629.21
Molecule Type: Unknown
Associated Items:
Canonical SMILES: Cc1cc(C(=O)NC(C)C)ccc1-c1ccc(C[C@H](NC(=O)[C@H]2CC[C@H](CN)CC2)C(=O)Nc2cc(Cl)c3cn[nH]c3c2)cc1
Standard InChI: InChI=1S/C35H41ClN6O3/c1-20(2)39-34(44)26-12-13-28(21(3)14-26)24-8-4-22(5-9-24)15-32(41-33(43)25-10-6-23(18-37)7-11-25)35(45)40-27-16-30(36)29-19-38-42-31(29)17-27/h4-5,8-9,12-14,16-17,19-20,23,25,32H,6-7,10-11,15,18,37H2,1-3H3,(H,38,42)(H,39,44)(H,40,45)(H,41,43)/t23-,25-,32-/m0/s1
Standard InChI Key: ORMQTCXHSFQLQX-OZVHGCLQSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 629.21 | Molecular Weight (Monoisotopic): 628.2929 | AlogP: 5.76 | #Rotatable Bonds: 10 |
Polar Surface Area: 142.00 | Molecular Species: BASE | HBA: 5 | HBD: 5 |
#RO5 Violations: 2 | HBA (Lipinski): 9 | HBD (Lipinski): 6 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 11.58 | CX Basic pKa: 10.20 | CX LogP: 5.04 | CX LogD: 2.59 |
Aromatic Rings: 4 | Heavy Atoms: 45 | QED Weighted: 0.15 | Np Likeness Score: -1.33 |
1. Steinmetzer T, Pilgram O, Wenzel BM, Wiedemeyer SJA.. (2020) Fibrinolysis Inhibitors: Potential Drugs for the Treatment and Prevention of Bleeding., 63 (4): [PMID:31658420] [10.1021/acs.jmedchem.9b01060] |
Source(1):